Microfluidic Photodynamic Therapy Based on Singlet Oxygen Fluorescence Sensing

SUN Yuran,PENG hongshang
DOI: https://doi.org/10.37188/cjl.20240145
2024-01-01
Chinese Journal of Luminescence
Abstract:Photodynamic therapy(PDT),as a new type of phototherapy technology,has the advantages of non-inva-sive and low toxic side effects,and has important application prospects in clinical medicine.Currently,PDT research is mainly based on statically cultured tumor cells,which significantly differ from the actual tumor microenvironment and often lead to poor clinical efficacy of PDT.This paper designs and develops a microfluidic biochip for tumor PDT,and prepares a fluorescent nanosensor(λex=410 nm,λem=460 nm)to fluorescently sense the production of singlet oxygen during the PDT process,analyzing the main factors affecting the inactivation of tumor cells by PDT.The results show that reducing the pH of the culture medium from 7.4 to 6.8(environmental acidification)and increasing the injection flow rate from 5 μL/h to 20 μL/h(increased shear stress)both reduce the phagocytic efficiency of tumor cells towards nano photosensitizers.In the early stage of PDT,the oxygen content is sufficient(<30 s),and the differences in photo-sensitizer dosage,microacidification,and mechanical microenvironment have little effect on the yield of singlet oxy-gen.The cell phototoxicity is similar.In the late stage of PDT(30-180 s),the oxygen content decreases,the yield of singlet oxygen decreases,and different tumor microenvironment parameters result in different cellular phototoxicity.This work explores the production of singlet oxygen during PDT in a simulated tumor microenvironment through fluores-cence sensing,providing useful references for promoting the clinical development of tumor PDT.
What problem does this paper attempt to address?